期刊文献+

减重手术治疗2型糖尿病机制研究进展 被引量:3

Mechanism research progress of bariatric surgery for type 2 diabetes mellitus
原文传递
导出
摘要 2型糖尿病患者接受减重手术后糖尿病症状显著缓解并能长期维持,主要是因为术后胃肠道激素的改变,此外体质量下降、饮食减少以及其他的因素也起着一定作用。随着其治疗机制研究的不断深入,减重手术有望成为治疗2型糖尿病的一种主要手段。 Patients with type 2 diabetes mellitus experienced a complete and comfirm diabetic remission after bariatric surgery. Although weight loss, reduction of food intake and other factors may play important roles in diabetic resolution after bariatric surgery, the major mechanism is the change of gastrointestinal hormones. Further research is essential to better understand these mechanisms and bariatric surgery may ultimately become a major tool in the treatment of type 2 diabetes mellitus.
出处 《中华胃肠外科杂志》 CAS 2012年第11期1207-1209,共3页 Chinese Journal of Gastrointestinal Surgery
基金 卫生部科技发展中心项目(W2011TNB52)
关键词 减重手术 2型糖尿病 机制 Bariatric surgery Type 2 diabetes Mechanism
  • 相关文献

参考文献35

  • 1Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010,362 (12): 1090-1101.
  • 2Proies WJ, MacDonald KG Jr, Morgan E J, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr, 1992,55(2 Suppl):582S-585S.
  • 3Flatt PR.Dorothy Hodgkin Lecture 2008.Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes? Diabet Med, 2008,25(7):759-764.
  • 4Lee HC, Kim MK, Kwon HS, et al. Early changes in incretinsecretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg, 2010,20( 11 ):1530-1535.
  • 5Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg, 2006,244(5):741-749.
  • 6Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA, 2004,292(14): 1724-1737.
  • 7李鹏洲,朱晒红,张大伟,刘岩,王国慧,朱利勇,叶飞.葡萄糖依赖性促胰岛素释放肽在胃肠转流术治疗2型糖尿病中的作用[J].中南大学学报(医学版),2011,36(10):1017-1020. 被引量:2
  • 8Sun Y, Asnicar M, Smith RG. Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendoerinology, 2007,86 (3) :215-228.
  • 9Dezaki K, Sone H, Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther, 2008,118 (2) : 239-249.
  • 10j Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med, 2002,346(21) : 1623-1630.

二级参考文献34

  • 1Kasuga M. Insulin resistance and pancreatic β cell failure [ J ]. J Clin Invest ,2006,116 ( 7 ) : 1757-1760.
  • 2Mingrone G, Nolfe G, Gissey G C, et al. Circadian rhythmsof GIP and GLP1 in glucose tolerant and in type 2 diabetic patients after biliopacreatic diversion [ J 1. Diabetologia, 2009,52 ( 5 ) : 873 -881.
  • 3Salinari S, Bertuzzi A, Asnaghi S,et al. First-phase insulin se- cretion restoration and differential response to glucose load de- pending on the route of administration in type 2 diabetic sub- jects after bariatric surgery [ J ]. Diabetes Care, 2009,32 ( 3 ) : 375-380.
  • 4Girard J. The incretins: From the concept to their use in the treatment of 2 diabetes. Part A: inc-Retins: Concept and physiological functions [ J ~. Diabetes Metab, 2008,34 ( 6 ptl) :550-559.
  • 5Ballinger A. Gastric inhibitory polypeptide links ovemutrition to obesity[ J]. Gut,2007,52(3 ) :319-320.
  • 6Jepeal L I, Boylan M O, Wolfe M M. Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene functions through a GATA and an ISL-1 motif in a mouse neuroendocrine tumor cell line[ J]. Regul Pept ,2003,113 ( 1/3 ) : 139-147.
  • 7Drucker D J. The role of gut hormones in glucose homeostasis [ J ]. J Clin Invest ,2007,117 ( 1 ) :24-32.
  • 8Deacon C F, Nauck M A, Meier J, et al. Degradation of endog- enous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide[ J]. J Clin Endocrinol Metab,2000,85 (10) : 3575-3581.
  • 9Trumper A, Trumper K, Horsch D. Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic pol- ypeptide in beta ( INS-1 ) ceils [ J ]. J Endocrinol, 2002, 174 (2) :233-239.
  • 10Ehses J A,Casilla V R,Doty T,et al. Glucose-dependent insuli- nnotropic polypeptide promotes beta ( INS-1 ) cell survival via cyclic adenosine monophophate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase [ J]. En-doerinology, 2003,144 ( 10 ) : 33-44.

共引文献1

同被引文献20

  • 1American Diabetes Association. Standards of medical care in dia- betes -2014 [ J]. Diabetes Care. 2014, 37 Suppl 1: S14- S80. doi: 10. 2337/dc14-s014.
  • 2Meijer RI, van Wagensveld BA, Siegert CE, et al. Bariatric sur- gery as a novel treatment for type 2 diabetes mellitus : a systematic review[J]. Arch Surg, 2011, 146(6) :744-750. doi: 10. 1001/ archsurg. 2011. 134.
  • 3Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric sur- gery for weight loss and glycemic control in nonmorbidly obese a- dults with diabetes: a systematic review[ J]. JAMA, 2013, 309 (21) :2250-2261. doi: 10. 1001/jama. 2013.4851.
  • 4Garciacaballero M, Navarrete S, Favretti F, et al. Diabetes sur- gery in type 2 BMI 24-29 vs IMC 30-34 diabetic patients: is there differences among restrictive, malabsorptive and gastric bypass procedures? [ J]. Nutr Hosp, 2013,28 Suppl 2:23-30. doi: 10. 3305/nh. 2013.28. sup2. 6710.
  • 5Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med, 2012, 366(17): 1577-1585.
  • 6Hutter MM, Sehirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass [J]. Ann Surg, 2011, 254: 410-420.
  • 7Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012, 366(17): 1567- 1576.
  • 8Cui JF, Chela T, Shi L, et al. Gastric bypass surgery in non-obese patients with type 2 diabetes mellitus:a 1-year follow-up 58 cases in chinese [J]. Int J Clin Exp Med, 2015,8 ( 3 ) : 4393-4396.
  • 9Isbell JM, Tamboli RA, Hansen EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery[J]. Diabetes Care, 2010, 33(7): 1438-1442.
  • 10李桢,张红亚,梁炜,李保东,李东飞,戴景兴,原林.Roux-en-Y胃肠道重建改善非肥胖性糖尿病胃癌患者的糖脂代谢[J].中华普通外科杂志,2010,25(1):4-8. 被引量:8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部